BE THE CEO OF CTO
While others are waiting, you’re innovating. And that can make all the difference in your CTO program. Now you can leverage the hybrid approach to treat chronic total occlusions safely — with maximum efficiency and success. And we’ll be there alongside you, with specialized training, ongoing case support, and, of course, unique tools.
CTOs occur in as many as 30% of patients with significant coronary artery disease. 1,2
PCI OR CABG
Patients with CTOs are most often treated with medical therapy or coronary artery bypass graft (CABG) rather than PCI.3
Recent meta-analyses and large registries have shown that successful CTO PCI is associated with symptom relief, a reduction in long-term mortality, and a lower need for coronary artery bypass graft (CABG) surgery.4,5
CROSSBOSS™ Coronary CTO Crossing Catheter
Designed to quickly and safely deliver a guidewire via the true lumen or subintimal pathways, CROSSBOSS Catheter gives you total access to coronary chronic total occlusions.
STINGRAY™ LP Coronary CTO Re-Entry System
Designed for reliability, safety, and predictability, the STINGRAY LP System allows the operator to accurately target and re-enter the true lumen from a subintimal position.